Oarsman Capital, Inc. reports 5.97% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,44 € ↑0,88 (1,88%)

2026-06-03
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Oarsman Capital, Inc.
Latest Disclosed Ownership	41,654 shares
Latest Disclosed Value	$ 2,526,289

On April 27, 2026 - Oarsman Capital, Inc. filed a 13F-HR form disclosing ownership of 41,654 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,183,503 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 39,306 shares of Bristol-Myers Squibb Company. This represents a change in shares of 5.97% during the quarter. The current value of the position is $1,975,857 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-27	2026-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	41,654	2,348	5.97	2,526	19.15	0.3136
2026-02-13	2025-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	39,306	1,532	4.06	2,120	24.49	0.2751
2025-11-21	2025-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	37,774	-1,909	-4.81	1,704	-7.24	0.2388
2025-08-01	2025-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	39,683	4,043	11.34	1,837	-15.51	0.2880
2025-05-14	2025-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	35,640	9,483	36.25	2,174	46.92	0.3905
2025-02-13	2024-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	26,157	281	1.09	1,479	10.54	0.2577
2024-11-08	2024-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	25,876	981	3.94	1,339	29.53	0.2465
2024-08-12	2024-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	24,895	-4,138	-14.25	1,034	-34.37	0.2264
2024-05-15	2024-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	29,033	1,012	3.61	1,574	9.53	0.3761
2024-02-16	2023-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	28,021	554	2.02	1,438	-9.85	0.3816
2023-10-27	2023-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	27,467	4,638	20.32	1,594	9.25	0.6662
2023-08-10	2023-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	22,829	-313	-1.35	1,460	-8.98	0.6391
2023-05-11	2023-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	23,142	387	1.70	1,604	-2.08	0.7498
2023-02-09	2022-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	22,755	522	2.35	1,637	3.54	0.8358
2022-11-10	2022-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	22,233	-425	-1.88	1,581	-9.40	0.8473
2022-08-10	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	22,658	-1,820	-7.44	1,745	-2.40	0.8665
2022-05-11	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	24,478	305	1.26	1,788	18.65	0.6983
2022-02-10	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	24,173	-160	-0.66	1,507	4.65	0.5941
2021-11-12	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	24,333	-973	-3.84	1,440	-14.84	0.5829
2021-08-12	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	25,306	-7,420	-22.67	1,691	-18.15	0.6718
2021-05-12	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	32,726	-5,664	-14.75	2,066	-13.23	0.8939
2021-02-11	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	38,390	195	0.51	2,381	3.39	0.9251
2020-11-12	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	38,195	1,855	5.10	2,303	7.77	1.0377
2020-08-13	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	36,340	20,950	136.13	2,137	149.07	1.0560
2020-05-13	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	15,390	10,982	249.14	858	203.18	0.7923
2020-02-13	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	4,408	4,408		283		0.1294
2019-02-13	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	0	-3,550	-100.00	0	-100.00
2018-11-07	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	3,550	-200	-5.33	220	5.77	0.0886
2018-08-10	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	3,750	-192	-4.87	208	-16.47	0.0945
2018-05-14	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	3,942	192	5.12	249	8.26	0.1133
2018-02-08	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	3,750	-26	-0.69	230	-4.56	0.0990
2017-11-13	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	3,776	0	0.00	241	14.76	0.1019
2017-08-10	2017-06-30	13F	Bristol-Myers Squibb	COM	110122108	3,776	1	0.03	210	2.44	0.0960
2017-05-11	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	3,775	3,775		205		0.0954
2017-02-09	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	0	-3,775	-100.00	0	-100.00
2016-11-10	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	3,775	-550	-12.72	204	-35.85	0.1040
2016-08-12	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	4,325	25	0.58	318	15.64	0.1653
2016-05-12	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	4,300	0	0.00	275	-7.09	0.1463
2016-02-11	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	4,300	0	0.00	296	16.08	0.1656
2015-11-10	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	4,300	0	0.00	255	-10.84	0.1507
2015-08-13	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	4,300	-125	-2.82	286	0.35	0.1950
2015-05-14	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	4,425	0	0.00	285	9.20	0.1968
2015-02-06	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	4,425	0	0.00	261	15.49	0.1881
2014-11-06	2014-09-30	13F	Bristol-Myers Squibb	COM	110122108	4,425	0	0.00	226	5.12	0.1666
2014-08-08	2014-06-30	13F	Bristol-Myers Squibb	COM	110122108	4,425	0	0.00	215	-6.52	0.1560
2014-04-25	2014-03-31	13F	Bristol-Myers Squibb	COM	110122108	4,425	125	2.91	230	0.44	0.1775
2014-02-06	2013-12-31	13F	Bristol-Myers Squibb	COM	110122108	4,300	4,300		229		0.1839

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.